<document id="DDI-DrugBank.d603">
    <sentence id="DDI-DrugBank.d603.s0" text="When administered concomitantly with ProAmatine   , cardiac glycosides may enhance or precipitate bradycardia, A.V. ">
        <entity charOffset="37-46" id="DDI-DrugBank.d603.s0.e0" text="ProAmatine" type="brand" />
        <entity charOffset="52-69" id="DDI-DrugBank.d603.s0.e1" text="cardiac glycosides" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d603.s0.e0" e2="DDI-DrugBank.d603.s0.e1" id="DDI-DrugBank.d603.s0.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d603.s3" text="ProAmatine    has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. ">
        <entity charOffset="0-9" id="DDI-DrugBank.d603.s3.e0" text="ProAmatine" type="brand" />
        <entity charOffset="105-127" id="DDI-DrugBank.d603.s3.e1" text="fludrocortisone acetate" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d603.s3.e0" e2="DDI-DrugBank.d603.s3.e1" id="DDI-DrugBank.d603.s3.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d603.s4" text="The potential for supine hypertension should be carefully monitored in these patients and may be minimized by either reducing the dose of fludrocortisone acetate or decreasing the salt intake prior to initiation of treatment with. ">
        <entity charOffset="138-160" id="DDI-DrugBank.d603.s4.e0" text="fludrocortisone acetate" type="drug" />
    </sentence>
    </document>